Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Dr. Sahil Lal: A Visionary Leader Taking Metro Hospitals to New Heights with Heart and Strategy Health
  • Inovaantage inaugurates their Hyderabad centre giving renewed hope to IT professionals looking for jobs Technology
  • Merino Showcases an Integrated Laminate and Board Solution at Matecia 2026 East Edition Lifestyle
  • Gujarat’s first Hospitality and Convention Centre’s Gruh Pravesh will be held on 17th September 2023 in Surat Business
  • Elation Visas Strengthens Its Position as a Trusted Immigration Advisory in India Business
  • ‘Sunny Sanskari Ki Tulsi Kumari’ — A 2025 Festive Rom-Com That Flirts with Charm, Trips on Convention Entertainment
  • India’s premier tech summit Big CIO Show brings together the nation’s top IT minds Business
  • Gandhinagar University inaugurates state’s 1st AI Blockchain-driven Cyber Security and Digital Forensics Lab Education

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Transforming Smiles Across India: Simpladent Clinics Leads with Advanced Implant Solutions Health
  • Pink Nutrition: Mother’s Diet as the First Shield Against Breast Cancer Health
  • In urban India, 50 million people in 15 cities have no access to safe, affordable drinking water: Report English
  • Unlocking the Future of Cancer Care: The Role of NGS and Molecular Biology Health
  • Unlocking the Secrets to Optimal Liver Health Health
  • MAI partners with Dr Reddy’s to promote awareness on Physical Activity for Arthritis Patients Health

Recent Posts

  • VerSe Innovation Unveils ‘Spark Station’, a Global AI Content Platform at Film Expo 2026
  • MET Honoured by Dr Shashi Tharoor at India@2047 Summit, IIT Delhi
  • Cupid Limited Receives In-Principle Board Approval For South African Manufacturing Venture
  • The Work Beneath the Work: Inside Tutul Consulting’s Approach to Organizational Transformation
  • Invertis University Secures Top 4 Finish at HAL x IIT Indore Aerothon 2026

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • 1xBet launches charitable water purification initiative in Indore Business
  • Beyond the Backbench: How Popular IAS Officer Hari Chandana Can Revolutionize Hyderabad’s Classrooms Education
  • Mark the Festival of Lights with Angie Homes Festive Collection Business
  • Sangeeta Sikdar Bhatia: Shaping Careers Beyond the Spotlight Lifestyle
  • Indian Gaming Industry and its Contribution to the Global Gaming Scenario: Take a Tour With GammaStack Business
  • ASG Eye Hospital Raises Awareness on Retinoblastoma: Early Detection Can Save Children’s Vision Health
  • Morari Bapu launches Shemaroo’s ‘Shri Ram Bhakti Utsav’ musical series celebrating Ram Lala’s Pran Pratishtha at Ayodhya National
  • With global stress impacting construction costs, Bigbloc Construction focuses on efficient building methods Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme